- Global Pharma News & Resources

Revenue and growth forecasts from 2021 to 2031 for the Global Clinical Trial Supplies Market

Visiongain has published a new report on Clinical Trial Supplies Market Report : Forecasts by Products & Services (Manufacturing, Packaging, Logistics, Distribution and Storage), Phases (l, ll, lll, lV), Drug Type (Small Molecule, Biologics), Therapeutic Areas (Oncology, Blood Disorders. PLUS Profiles of Leading Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.

COVID-19 Impact on Clinical trial supplies Market
By the impact of COVID19 the clinical trial supply industry have a challenge to keep their trials in continuation. It is very important to distribute drug product among different regions and receive biological trials and transfer those samples to central labs, because of this pandemic the market is moving again in decentralised model of conducting clinical trials for result in high recovery rate of covid19 patients. Due to restriction on logistic industry it is very important to understand to manage clinical trials.

Click here to Get Complete Synopsis of the Report @

How the Clinical Trial Supplies Market report helps you
In summary, our 150+ page report provides you with the following knowledge:
– Revenue forecasts to 2031 for each of the above mentioned segments each forecasted at a global and regional level– growth of all segments on regional level helps to understand most lucrative segment.

– Revenue forecasts to 2031 for 5 regional and 10 key national markets – the report highlights market growth prospects for key countries such as the U.S., Canada, Germany, UK, France, Italy, Spain, China, Japan, and India. The report also highlights growth potential in Central & South America as well as Middle East & Africa.

– Prospects for established firms and those seeking to enter the market– including company profiles for over 10 of the major companies involved in the Clinical Trial Supplies market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence

Market Drivers
Clinical phase insights- phase 1 is expected to grow faster due to increase in number of outsourced phase 1 trials. Outsourcing is increasing because of lesser population sample and higher capital investment.

End use insights- biologics is expected to grow faster based on end use while pharmaceutical is expected to grow faster in forecast period.

Get Complete Synopsis of the Report @

Market Opportunities
Opportunity 1- due to the presence of well-established CROs and growing investment in R&D by pharmaceutical and biopharmaceutical companies the demand in clinical trials is increased.

Opportunity 2- due to COVID19 pandemic the pharma companies is outsourcing the trails for better medicine and in search for launching the vaccines.

Competitive Landscape
- CROs are witnessing strong growth in the global clinical trial material and supplies market
- Clinical trial materials and supplies market is becoming more and more fragmented and expected to experience huge changes in terms of competition
- Recent partnership acquisition and expansion have taken place in the global clinical trial market and supplies market.
- Major players in the market include: Alamc Group (UK), Catalent, Inc. (US), PCI Services (US), Parexel International Corporation (US), Sharp Packaging Services (US), Biocair (UK), O&M Movianto (US), KLIFO A/S (Denmark), Thermo Fisher Scientific, Inc. (US), Capsugel (Switzerland), UDG Healthcare Plc. (Ireland), Bilcare Limited (India), Infosys (India), PRA Health Sciences, Inc. (US), Eurofins Scientific (Luxembourg), Marken (US), Seveillar Clinical Trial Supplies Pvt. Ltd. (India), and N-SIDE (Belgium).

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help:

About Visiongain

Visiongain is one of the fastest-growing and most innovative independent market research and consulting company in Europe. Based in London, UK, the company comprises over 400+ analysts and consultants, adding more than 1400 market research reports to its vast database each year. These reports offer in-depth analysis on 18 industries worldwide. With the help of an interactive market intelligence platform, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.


Sara Peerun
Commercial Director
Visiongain Limited
Phone: +44 (0) 20 7549 9987.

Revenue and growth forecasts from 2021 to 2031 for the Global Clinical Trial Supplies Market

Editor Details

Related Links

Last Updated: 23-Apr-2021